Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Bellerophon Therapeutics, Inc. (BLPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/31/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/11/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 04/06/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 03/14/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 05/17/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
| 03/15/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 03/17/2017 |
10-K/A
| Annual Report for the period ended December 31, 2016 [amend] |
| 03/13/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 03/21/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 03/31/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
|
|